Eos were also detected in the non-IBD intestinal mucosa; but the frequency (11.6% ±2.2%;) of CD98+ Eos was significantly lower in the non-IBD specimens than that in the IBD intestinal mucosa. Here, SLC3A2 is linked to inflammatory bowel disease.